Printer Friendly

Entia Biosciences Inc unveils ErgoD2 Flex-RA medical food for Rheumatoid Arthritis.

M2 EQUITYBITES-May 3, 2012-Entia Biosciences Inc unveils ErgoD2 Flex-RA medical food for Rheumatoid Arthritis(C)2012 M2 COMMUNICATIONS http://www.m2.com

Food science company Entia Biosciences Inc (ERGO.OB) (ENTIA) reported on Wednesday the launch of a new medical food, called ErgoD2 Flex-RA, for the treatment of Rheumatoid Arthritis (RA).

Rheumatoid Arthritis (RA) is a systemic autoimmune disease that causes pain, stiffness, swelling and loss of function in the joints.

The company added that ErgoD2 Flex-RA is an encapsulated medical food product with active anti-inflammatory bionutrients formulated to improve immune function, control joint inflammation and potentially mediate systemic and local RA symptoms.

According to a study presented at the 2008 European Union League Against Rheumatism (EULAR) meeting in Paris, nearly 75% of patients, including those who were subsequently diagnosed with inflammatory joint diseases, soft-tissue rheumatism, uncomplicated musculoskeletal backache or osteoporosis, were deficient in vitamin D.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:May 3, 2012
Words:157
Previous Article:USANA Health Sciences Inc names female entrepreneur Jen Groover as company spokesperson.
Next Article:EVERTEC and EVERTEC Finance Corp price offering of USD40m Senior Notes due 2018.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters